Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OLIGO-10: Stereotactic Ablative Radiation Therapy for Metastatic Patients (6-10 Metastases): A Prospective Phase II Single-Arm Trial

NCT06856603 is registered in ClinicalTrials.gov with National Medical Research Radiological Centre of the Ministry of Health of Russia as lead sponsor.

NCT NCT06856603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06856603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OLIGO-10: Stereotactic Ablative Radiation Therapy for Metastatic Patients (6-10 Metastases): A Prospective Phase II Single-Arm Trial
Lead sponsor
National Medical Research Radiological Centre of the Ministry of Health of Russia
Phase
Phase 2
Overall status
Recruiting
Start date
February 7, 2025
Completion date
December 31, 2030
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic disease